Efficacy and Safety Study as Monotherapy of Satralizumab (SA237) to Treat NMO and NMOSD

Purpose

By examining the health status of patients with cystic fibrosis annually, valuable information has (and will continue) to be gained about the trends in nutrition, medical problems, lung transplantation and bacterial colonization in patients with cystic fibrosis. Collection and analysis of this information (which is collected on every CF patient in North America) allows CF care teams to improve in their knowledge of the disease and to change the way they care for patients with CF appropriately.

Category

• Lungs, Breathing and Bronchial